and Region/Country Geography: Industry: Last Updated: Feb 2025 The GLP-1 Analogues Market was valued at approximately USD 37 Billion in 2023 and is expected to grow at a substantial CAGR of around 28% during the forecast period (2024-2032) owing to the rising prevalence of type 2 diabetes and obesity
The black box warning that the FDA has added to Ozempic and other semaglutide products cautions users of the increased risk of developing thyroid tumors and thyroid cancer
Safety Monitoring Framework for Dual Therapy Safe concurrent use of GLP-1 and berberine depends on regular clinical assessment including fasting glucose, HbA1c, liver function tests, and kidney markers
Due to their anti-inflammatory and pro-regenerative effects, recombinant human BMPs are used for bone grafting in vertebral fusion surgery as well as disc tissue engineering (95, 96)
doi: 10.1056/NEJMra073096 15 BertilssonG.PatroneC.ZachrissonO.AnderssonA.DannaeusK.HeidrichJ.et al
Whether due to eligibility, personal preference, cost, or side effects, there are many people not taking GLP-1s who could still benefit from a wellness initiative
